Location History:
- Arbutus, MD (US) (2014)
- Baltimore, MD (US) (2012 - 2023)
Company Filing History:
9 out of 3,687 
6 out of 1,823 
Years Active: 2012-2023
Title: Innovations and Contributions of David Raymond Graham
Introduction
David Raymond Graham, a prominent inventor based in Arbutus, MD, has made significant strides in the field of virology with a portfolio of nine patents. His work highlights innovative methods for altering viral structures and improving treatment options, particularly in relation to viral infections.
Latest Patents
Among his latest contributions, Graham has developed methods for increasing the infectivity of viruses using alkyne-modified fatty acids. His patented methodologies encompass techniques for labeling viruses, like the human immunodeficiency virus, with alkyne-modified biomolecules, including fatty acids, carbohydrates, and lipids. These advancements facilitate the development of pharmaceutical compositions capable of treating infections in plants, insects, or animals. Additionally, his work explores the possibility of combining these labeled viruses with pharmaceutical excipients to enhance efficacy, potentially integrating other anti-viral agents or delivery systems such as liposomes.
Career Highlights
David Graham has had a notable career, contributing to reputable organizations such as The Johns Hopkins University and Life Technologies Corporation. His innovative research and development efforts in these institutions have fostered new methodologies in treating viral infections.
Collaborations
Throughout his career, Graham has collaborated with various esteemed professionals, including Brian Agnew and Upinder Singh. These collaborations have not only bolstered his research outcomes but also enriched the scientific community's understanding of virus infectivity and treatment methodologies.
Conclusion
David Raymond Graham stands out as a vital inventor in the realm of virology. His extensive patent portfolio showcases his dedication to innovation and the advancement of treatments for viral infections. Through groundbreaking techniques employing alkyne-modified biomolecules, he is paving the way for future developments in pharmaceutical applications, ultimately enhancing the fight against viral diseases.